PDSB - PDS Biotechnology Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PDSB is currently covered by 3 analysts with an average price target of $11.31. This is a potential upside of $10.1 (834.71%) from yesterday's end of day stock price of $1.21.

PDS Biotechnology Corp's activity chart (see below) currently has 11 price targets and 31 ratings on display. The stock rating distribution of PDSB is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for PDSB is $13, Lowest price target is $7, average price target is $13.33.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 01-Jul-2025. First documented stock forecast 09-Jun-2021.

Best performing analysts who are covering PDSB - PDS Biotechnology Corp:

Joseph Pantginis Leland Gershell Kalpit Patel

Currently out of the existing stock ratings of PDSB, 22 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$11.76 (948.39%)

$13

15 days ago
(01-Jul-2025)

0/15 (0%)

$11.78 (965.57%)

Buy

$7

$5.76 (464.52%)

$9

7 months 21 days ago
(25-Nov-2024)

0/4 (0%)

$4.83 (222.58%)

Buy

$20

$18.76 (1512.90%)

$24

1 years 8 months 1 days ago
(15-Nov-2023)

0/4 (0%)

$13.68 (216.46%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PDSB (PDS Biotechnology Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on PDSB (PDS Biotechnology Corp) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the current lower performing score on PDSB (PDS Biotechnology Corp) with a proven track record?

KALPIT PATEL

Which analyst has the most public recommendations on PDSB (PDS Biotechnology Corp)?

Joseph Pantginis has 32 price targets and 24 ratings on PDSB

Which analyst is the currently most bullish on PDSB (PDS Biotechnology Corp)?

Leland Gershell with highest potential upside - $18.76

Which analyst is the currently most reserved on PDSB (PDS Biotechnology Corp)?

Kalpit Patel with lowest potential downside - $5.76

PDS Biotechnology Corp in the News

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., May 09, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that on May 5, 2025, PDS Biotech granted a nonstatutory stock option to purchase 5,000 shares of common stock to...

PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentation PRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that an abstract submitted by the National Cancer...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?